Vanguard Group’s Decibel Therapeutics, Inc. Common Stock DBTX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q3 | – | Sell |
-642,325
| Closed | -$2.47M | – | 4574 |
|
2023
Q2 | $2.47M | Hold |
642,325
| – | – | ﹤0.01% | 3588 |
|
2023
Q1 | $1.94M | Buy |
642,325
+15,021
| +2% | +$45.4K | ﹤0.01% | 3681 |
|
2022
Q4 | $1.29M | Buy |
627,304
+4,367
| +0.7% | +$8.95K | ﹤0.01% | 3823 |
|
2022
Q3 | $2.16M | Hold |
622,937
| – | – | ﹤0.01% | 3705 |
|
2022
Q2 | $2.62M | Hold |
622,937
| – | – | ﹤0.01% | 3692 |
|
2022
Q1 | $1.89M | Sell |
622,937
-1,860
| -0.3% | -$5.65K | ﹤0.01% | 3980 |
|
2021
Q4 | $2.91M | Sell |
624,797
-418
| -0.1% | -$1.94K | ﹤0.01% | 3888 |
|
2021
Q3 | $4.82M | Buy |
625,215
+253,441
| +68% | +$1.95M | ﹤0.01% | 3688 |
|
2021
Q2 | $3.2M | Buy |
371,774
+188,515
| +103% | +$1.62M | ﹤0.01% | 3810 |
|
2021
Q1 | $2.08M | Buy |
+183,259
| New | +$2.08M | ﹤0.01% | 3855 |
|